The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies

To help address platelet shortages and streamline blood center operations, The Blood Center in New Orleans has become the ...
The American Journal of Managed Care

Practical Considerations for ITP Therapy Selection and Future Research

An expert discusses how rilzabrutinib’s oral administration and broad tolerability make it a practical treatment option while ...
Medscape

Europe Set to Approve New Immune Thrombocytopenia Therapy

The EMA has recommended a first-in-class Bruton’s tyrosine kinase inhibitor to treat immune thrombocytopenia in adults who are refractory to other treatments.

Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopeniaRecommendation based on LUNA 3 phase 3 study ...
The American Journal of Managed Care

The Value of Patient-Reported Outcomes in Choosing ITP Therapies

An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains ...